Biden wants a drug pricing plan in 45 days. Who’s going to write it?

Stat News

13 July 2021 - Medicare announced it’s opening a so-called National Coverage Determination for Biogen’s divisive new Alzheimer’s drug, Aduhelm. 

As wonky as that sounds, the determination will set the rules for who can access the $56,000 drug through Medicare.

Read Stat News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing